LifeScience Biologics
Klotho Neurosciences Advances KLTO-202 Gene Therapy Manufacturing for ALS Clinical Trials
Klotho Neurosciences, Inc. announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of K...
July 01, 2025 | News
WuXi Biologics Launches WuXiHigh™2.0 to Enable Record-Setting High-Concentration Biologic Formulations
The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces visc...
July 01, 2025 | News
ProBio Opens 128,000 sq ft Cell and Gene Therapy Center of Excellence in New Jersey to Accelerate Advanced Biomanufacturing
ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flags...
June 30, 2025 | News
SineuGene Therapeutics Receives FDA Orphan Drug Designation for Gene Therapy SNUG01 in ALS
SineuGene Therapeutics, a clinical-stage biotechnology company focused on gene therapies for neurological diseases, announced that the U.S. Food and Drug A...
June 27, 2025 | News
Invetech and AiCella Forge Strategic Alliance to Advance AI-Driven Cell Therapy Manufacturing
Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today anno...
June 27, 2025 | News
AGC Biologics Launches Cell Therapy Manufacturing Services in Yokohama to Expand Global CDMO Footprint
AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc....
June 26, 2025 | News
Silo Pharma and Hoth Therapeutics to Jointly Develop VA-Invented Biologic for Obesity and Metabolic Disorders
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therap...
June 26, 2025 | News
Xcell Biosciences and Thermo Fisher Scientific Unite to Advance Treg and TIL Cell Therapies for Autoimmune and Solid Tumor Diseases
Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic coll...
June 25, 2025 | News
EVA Pharma and CHICO Pharmaceutical Join Forces to Localize Oncology API Production for Middle East and Africa
On the sidelines of CPHI China 2025, EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle Eas...
June 25, 2025 | News
Illumina to Acquire SomaLogic for $350 Million, Expanding Proteomics Portfolio and Advancing Multiomics Vision
Combines highly complementary proteomics expertise with Illumina’s industry-leading product innovation and global market reach Positions Illumina to...
June 24, 2025 | News
Novogene Establishes Korean Subsidiary to Strengthen Multi-Omics Innovation and Local Collaboration
Novogene, a global leader in next-generation sequencing (NGS) and multi-omics solutions, today announced the establishment ofNovogene Korea ...
June 23, 2025 | News
Harbour BioMed and Otsuka Ink $670M+ Global Deal to Advance Bispecific T-Cell Engager for Autoimmune Diseases
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology,&nb...
June 23, 2025 | News
XtalPi and DoveTree Sign $100M+ LOI to Accelerate AI-Driven Drug Discovery Across Oncology and Neurology
XtalPi, a global leader in AI- and robotics-powered drug and materials discovery, announced it has signed a Letter of Intent (LOI) with DoveTre...
June 23, 2025 | News
Simcere Zaiming Doses First U.S. Patient in Phase 1 Trial of Trispecific Antibody SIM0500 for Relapsed/Refractory Multiple Myeloma
Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group announced the first US patient has started treatment in the ongo...
June 19, 2025 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
